Rheumatology in the digital health era: status quo and quo vadis?

Nat Rev Rheumatol. 2024 Dec;20(12):747-759. doi: 10.1038/s41584-024-01177-7. Epub 2024 Oct 31.

Abstract

Rheumatology faces a critical shortage of health-care professionals, exacerbated by an ageing patient population and escalating costs, resulting in widening gaps in care. Exponential advances in digital health technologies (DHTs) in the past 5 years offer new opportunities to address these challenges and could contribute to overall improved health care. However, keeping pace with innovations and integrating them into clinical practice can be challenging. This Review explores the transformative potential of DHTs for rheumatology in reshaping the entire patient pathway and redefining the roles of patients and providers, and discusses the potential barriers to DHT integration. Key technologies, such as large language models, clinical decision-support systems, digital therapeutics, electronic patient-reported outcomes, digital biomarkers, robots, self-sampling devices and artificial intelligence-based scribes, can be implemented along the patient pathway. A digital-first hybrid stepped-care patient pathway could combine in-person and remote care, enabling personalized and continuous monitoring through a digital safety net. The potential benefits and risks of transforming the traditional patient-provider relationship into a digital health triad with technology are discussed. Collaborative efforts are needed to navigate the evolving digital health landscape and harness the potential of DHTs to improve rheumatology care.

Publication types

  • Review

MeSH terms

  • Artificial Intelligence
  • Biomedical Technology / methods
  • Biomedical Technology / trends
  • Decision Support Systems, Clinical
  • Digital Health
  • Digital Technology
  • Humans
  • Rheumatic Diseases / diagnosis
  • Rheumatic Diseases / therapy
  • Rheumatology* / methods
  • Rheumatology* / trends
  • Telemedicine / trends